Acute Myeloid Leukemia

Disease State Hub

Polls

Research Summaries

Research Summary

Research Summary

UK Biobank and Preclinical Study Links Obesity to Myeloid Leukemia, Identifies Dual GLP-1R/IL-17A Strategy

08/11/2026

Anthony Calabro, MA

An integrated UK Biobank and preclinical study linked obesity-related metabolic inflammation to PTPN11-mutant myeloid leukemia and found that combined GLP-1R agonism and IL-17A blockade reduced leukemic...

08/11/2026

Timeline Snapshot

Notable FDA Approvals in May

05/29/2026

May 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a quick,...

05/29/2026

Conference Coverage

Long-Term Follow-Up Shows Continued Efficacy of Iomab B-Led Allogeneic Hematopoietic Cell Transplantation in Older Patients With Active, R/R AML

09/30/2024

Anthony Calabro, MA

In a long-term follow-up to SIERRA, a multicenter, randomized, controlled phase 3 study, researchers found that patients 55 years of age or older with active relapsed or refractory acute myeloid leukemia...

09/30/2024

Conference Coverage

Meta-Analysis: FLT3 Inhibitors vs Placebo for Patients With Acute Myeloid Leukemia

09/27/2024

Anthony Calabro, MA

Researchers who developed a meta-analysis of 19 randomized controlled trials found a statistically significant improvement in overall survival with sorafenib when compared with placebo for patients with...

09/27/2024

research summary

research summary

Venetoclax-Based Regimens Show Promising Efficacy, Safety Profile for Older Patients with AML

09/23/2024

Anthony Calabro, MA

Researchers conducted a meta-analysis examining the current evidence on the safety, efficacy, and predictive factors for venetoclax-based regimens in older adults with acute myeloid leukemia.

09/23/2024

August 2026

Current Issue

August 2026